Jennifer Sampson
About Jennifer Sampson
Jennifer Sampson is a Senior Director and Clinical Scientist at Adaptimmune, where she has worked since 2021. She has extensive experience in clinical research, having held various positions at Amgen and PRA Health Sciences over a career spanning more than two decades.
Current Role at Adaptimmune
Jennifer Sampson serves as the Senior Director, Clinical Scientist at Adaptimmune, a position she has held since 2021. In this role, she is responsible for leading clinical research initiatives and contributing to the development of innovative therapies. Her work is based in Abingdon, England, where she applies her extensive experience in clinical science to advance the company's mission.
Previous Experience at Amgen
Prior to her current role, Jennifer Sampson worked at Amgen in various capacities. She served as a Clinical Research Study Manager from 2005 to 2015 for ten years, overseeing clinical trials and ensuring compliance with regulatory standards. She then transitioned to the role of Clinical Program Operations Manager for eight months in 2015, followed by two years as Global Clinical Program - Senior Manager from 2016 to 2018, both based in Uxbridge.
Experience at PRA Health Sciences
Jennifer Sampson began her career at PRA Health Sciences, where she held multiple positions. She worked as a Clinical Research Associate (CRA) from 2000 to 2002, followed by a role as Lead CRA from 2002 to 2004. She later served as a Project Manager from 2004 to 2005. These roles were based in Reading, United Kingdom, and provided her with foundational experience in clinical research and project management.
Education and Expertise
Jennifer Sampson earned her Bachelor of Science degree in Chemistry with Pharmacology from the University of Southampton. She furthered her education at the same institution, achieving a Doctor of Philosophy (Ph.D.) in Bio-organic Chemistry. Her academic background supports her expertise in clinical science and research methodologies.
Career Progression
Jennifer Sampson has demonstrated a progressive career in the clinical research field, moving from entry-level roles to senior management positions. Her experience spans over two decades, with significant contributions to both Amgen and PRA Health Sciences before her tenure at Adaptimmune. This trajectory reflects her commitment to advancing clinical research and her ability to lead complex projects.